查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571887

心血管和軟組織修復貼片的全球市場

Cardiovascular and Soft Tissue Repair Patches
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球心血管和軟組織修復補片市場預計將達到 83 億美元

心血管和軟組織修復補片的全球市場預計 2023 年為 51 億美元，預計到 2030 年將達到 83 億美元，2023-2030 年分析期間複合年成長率為 7.4%。 ePTFE 原料是本報告分析的細分市場之一，預計複合年成長率為 7.2%，到分析期結束時將達到 50 億美元。分析期內，生物材料和組織工程材料領域的複合年成長率預計為 7.9%。

美國市場預計13億美元，中國預計複合年成長率11.1%

預計2023年美國心血管軟組織修復補片市場規模將達13億美元。中國作為世界第二大經濟體，預計2030年市場規模將達20億美元，2023-2030年分析期間複合年成長率為11.1%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 3.7% 和 6.7%。在歐洲，德國的複合年成長率預計為 4.4%。

全球心血管和軟組織修復貼片市場 - 主要趨勢和促進因素總結

為什麼心血管和軟組織修復補片對現代醫學至關重要？

心血管和軟組織修復補片是用於修復體內受損組織和結構的重要醫療設備，特別是在心血管手術和重組手術中。這些貼片由合成或生物材料製成，旨在促進組織癒合、支撐薄弱區域並恢復器官和組織的結構完整性。在心血管應用中，用於治療先天性心臟缺陷、動脈瘤、瓣膜性心臟病等。在軟組織修復中，它對於疝氣修復、腹壁重組和其他創傷相關損傷至關重要。

由於心血管疾病（CVD）盛行率的增加以及與組織修復相關的外科手術數量的增加，心血管和軟組織修復補片的需求顯著增加。隨著手術技術和材料的進步，這些補片為患者提供了更可靠、更持久的解決方案，促進更快的康復和更好的結果。此外，在貼片開發中使用生物相容性和生物可吸收材料可以增強身體的自然癒合過程，並減少感染疾病和免疫反應等併發症。這些貼片在現代醫學中變得至關重要，因為它們能夠支持患者的長期康復並減少再次手術的可能性。

科技進步如何形塑心血管和軟組織修復補片市場？

技術進步正在徹底改變心血管和軟組織修復補片市場，提高其有效性、耐用性和生物相容性。一項重要的進步是仿生貼片的使用。這些貼片通常由膠原蛋白或其他生物支架製成，融入患者體內並隨著時間的推移逐漸吸收，促進自然組織再生。這降低了排斥的風險並改善了治癒效果。此外，使用在組織癒合後溶解的生物可吸收材料消除了重新手術去除貼片的需要，提高了患者的舒適度並降低了醫療成本。

另一個重大進步是開發了具有更高耐用性和機械強度的合成補片。聚合物科學的創新已經開發出能夠承受高機械應力的貼片，使其適合在心臟等動態環境中使用。結合了生物和合成成分的混合貼片也越來越受歡迎，因為它們具有兩種材料的優點：促進組織生長，同時提供結構支撐。此外，3D 列印和奈米技術正在成為客製化補片生產的變革性工具，使外科醫生能夠根據患者的個別需求精確地客製化補片的形狀和尺寸。

哪些醫療和消費趨勢正在推動對心血管和軟組織修復貼片的需求？

一些醫療和消費趨勢正在影響對心血管和軟組織修復補片的需求，特別是慢性病盛行率的增加和對微創手術的日益重視。由於人口老化以及肥胖和高血壓等生活方式因素，心血管疾病的發生率不斷增加，導致全球心血管手術數量顯著增加。心血管補片對於治療各種心臟疾病至關重要，包括先天缺陷、動脈瘤和受損的心臟瓣膜，從而創造了這些醫療設備的穩定需求。此外，創傷相關損傷以及針對疝氣和軟組織斷裂等疾病的重組手術的增加增加了對可靠軟組織修復解決方案的需求。

推動需求的另一個主要趨勢是人們越來越偏好微創手術，因為微創手術可以提供更快的恢復時間和更少的併發症。軟組織修補補片，特別是那些為腹腔鏡手術設計的補片，在微創疝氣修補和腹部手術中越來越受歡迎。現今的患者更加意識到微創治療的好處，並尋求能夠更快恢復和緩解疼痛的手術。用於此類手術的先進、靈活、生物可吸收貼片的開發符合這種微創選擇的需求。此外，人們對感染疾病和補片失敗等術後併發症的認知不斷提高，促使外科醫生和醫療保健提供者選擇高品質、高度生物相容性的材料來改善患者的治療效果。對減少手術併發症和提高患者滿意度的重視正在推動心血管和軟組織修復補片的設計和功能創新。

心血管和軟組織修復補片市場的成長受到多種因素的推動。

心血管和軟組織修復補片市場的成長受到多種因素的推動，包括心血管和軟組織疾病發病率的增加、補片材料和設計的進步以及對微創手術解決方案的需求不斷增加。主要促進因素之一是全球心血管疾病負擔不斷增加，心血管疾病仍是全球第一大死因。動脈瘤、先天性心臟疾病和瓣膜性心臟病等疾病的手術數量不斷增加，推動了對心血管修復補片的需求，特別是那些具有改善的生物相容性和耐用性的補片。

生物工程和合成貼片材料的技術進步也是市場成長的重要因素。生物可吸收貼片和混合材料等創新結合了生物和合成成分的最佳特性，使這些設備對患者更有效、更安全。此外，可根據患者獨特的解剖學需求量身定做的 3D 列印貼片的開拓正在擴大個人化醫療設備市場。對微創手術技術的日益關注進一步推動了市場的發展。軟組織修補補片，特別是用於腹腔鏡疝氣修補手術的補片，需求量很大，因為它們可以縮短恢復時間並最大限度地減少疤痕。隨著醫療保健提供者擴大採用微創方法，對靈活、易於使用和高效能貼片的需求預計將會成長。此外，先進醫療基礎設施的不斷擴大和新興市場醫療保健支出的增加正在為市場擴張創造新的機會。隨著全球醫療保健系統繼續優先考慮創新、安全和以患者為中心的護理，心血管和軟組織修復補片市場有望持續成長。

受訪企業範例（共42家）

  • Abbott（St Jude Medical）
  • Admedus
  • Atriummed
  • B.Braun
  • Bard Peripheral Vascular, Inc.
  • Baxter
  • CorMatrix
  • Cryolife, Inc.
  • Edwards Life Sciences Corporation
  • GETINGE Group
  • Glycar SA Pty Ltd.
  • Gunze Limited
  • LabCor
  • LeMaitre Vascular Inc.
  • Maverick Bioscience
  • Medtronic
  • Neovasc
  • Novomedics
  • Perouse Medical
  • Southern Lights Biomaterials
  • TEI Biosciences Inc.
  • Terumo Medical Corporation
  • WL Gore & Associates, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP21438

Global Cardiovascular and Soft Tissue Repair Patches Market to Reach US$8.3 Billion by 2030

The global market for Cardiovascular and Soft Tissue Repair Patches estimated at US$5.1 Billion in the year 2023, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. ePTFE Raw Material, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$5.0 Billion by the end of the analysis period. Growth in the Biomaterial & Tissue Engineered Material segment is estimated at 7.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 11.1% CAGR

The Cardiovascular and Soft Tissue Repair Patches market in the U.S. is estimated at US$1.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Cardiovascular and Soft Tissue Repair Patches Market – Key Trends & Drivers Summarized

Why Are Cardiovascular and Soft Tissue Repair Patches Essential in Modern Medicine?

Cardiovascular and soft tissue repair patches are critical medical devices used to repair damaged tissues and structures within the body, particularly in cardiac surgeries and reconstructive procedures. These patches, made from either synthetic or biological materials, are designed to facilitate tissue healing, support weakened areas, and restore the structural integrity of organs and tissues. In cardiovascular applications, they are used to treat conditions like congenital heart defects, aneurysms, and valvular diseases. For soft tissue repair, these patches are essential in hernia repairs, abdominal wall reconstruction, and other trauma-related injuries.

The demand for cardiovascular and soft tissue repair patches has risen significantly due to the increasing prevalence of cardiovascular diseases (CVDs) and the growing number of surgical procedures related to tissue repair. With advancements in surgical techniques and materials, these patches provide a more reliable, durable solution for patients, promoting faster recovery and better outcomes. Furthermore, the use of biocompatible and bioresorbable materials in patch development enhances the body's natural healing processes, reducing complications such as infections or immune reactions. These patches have become indispensable in modern medicine for their ability to support long-term patient recovery and reduce the likelihood of surgical re-intervention.

How Are Technological Advancements Shaping the Cardiovascular and Soft Tissue Repair Patches Market?

Technological advancements are revolutionizing the cardiovascular and soft tissue repair patches market, improving their effectiveness, durability, and biocompatibility. One significant development is the use of bioengineered patches, which are designed to mimic the body’s natural tissues. These patches, often derived from collagen or other biological scaffolds, promote natural tissue regeneration by integrating into the patient’s body and gradually being absorbed over time. This reduces the risk of rejection and improves healing outcomes. Additionally, the use of bioresorbable materials that dissolve after the tissue has healed eliminates the need for follow-up surgeries to remove the patches, improving patient comfort and reducing healthcare costs.

Another major advancement is the development of synthetic patches with enhanced durability and mechanical strength. Innovations in polymer science have led to the creation of patches that can withstand high mechanical stresses, making them suitable for use in dynamic environments such as the heart. Hybrid patches, which combine both biological and synthetic components, are also gaining popularity as they offer the benefits of both materials, providing structural support while encouraging tissue growth. Furthermore, 3D printing and nanotechnology are emerging as transformative tools in the production of customized patches, allowing surgeons to tailor the shape and size of patches to fit individual patient needs precisely.

What Medical and Consumer Trends Are Driving the Demand for Cardiovascular and Soft Tissue Repair Patches?

Several medical and consumer trends are shaping the demand for cardiovascular and soft tissue repair patches, particularly the increasing prevalence of chronic diseases and the growing emphasis on minimally invasive procedures. The rise in cardiovascular diseases, driven by aging populations and lifestyle factors like obesity and hypertension, has significantly increased the number of cardiac surgeries worldwide. Cardiovascular patches are critical in treating a variety of heart conditions, including congenital defects, aneurysms, and damaged heart valves, creating a steady demand for these medical devices. Additionally, the rise in trauma-related injuries and the growing number of reconstructive surgeries for conditions like hernias and soft tissue tears have driven the need for reliable soft tissue repair solutions.

Another major trend driving demand is the growing preference for minimally invasive surgeries, which result in shorter recovery times and fewer complications. Soft tissue repair patches, especially those designed for laparoscopic procedures, have become increasingly popular in minimally invasive hernia repairs and abdominal surgeries. Patients today are more aware of the benefits of less invasive treatments and are seeking procedures that offer quicker recovery and reduced pain. The development of advanced, flexible, and bioresorbable patches that can be used in these types of surgeries is aligning with this demand for minimally invasive options. Moreover, the increasing awareness of postoperative complications, such as infections and patch failure, is prompting surgeons and healthcare providers to choose high-quality, biocompatible materials that improve patient outcomes. The emphasis on reducing surgical complications and enhancing patient satisfaction is fostering innovation in the design and functionality of cardiovascular and soft tissue repair patches.

Growth in the Cardiovascular and Soft Tissue Repair Patches Market Is Driven by Several Factors

Growth in the cardiovascular and soft tissue repair patches market is driven by several factors, including the increasing incidence of cardiovascular and soft tissue disorders, advancements in patch materials and design, and the rising demand for minimally invasive surgical solutions. One of the primary drivers is the growing global burden of cardiovascular diseases, which remains the leading cause of death worldwide. The increasing number of surgeries for conditions such as aneurysms, congenital heart defects, and valvular diseases is driving the demand for cardiovascular repair patches, particularly those that offer improved biocompatibility and durability.

Technological advancements in bioengineered and synthetic patch materials are another significant factor contributing to market growth. Innovations such as bioresorbable patches and hybrid materials that combine the best properties of biological and synthetic components are making these devices more effective and safer for patients. Additionally, the development of 3D-printed patches, which can be customized to match a patient’s specific anatomical needs, is expanding the market for personalized medical devices. The rising focus on minimally invasive surgical techniques is further boosting the market. Soft tissue repair patches, especially those used in laparoscopic surgeries for hernia repairs, are in high demand due to their ability to reduce recovery times and minimize scarring. As healthcare providers increasingly adopt minimally invasive approaches, the demand for flexible, easy-to-use, and high-performance patches is expected to grow. Moreover, the expanding availability of advanced healthcare infrastructure and rising healthcare spending in emerging markets are opening new opportunities for market expansion. As the global healthcare system continues to prioritize innovation, safety, and patient-centered care, the cardiovascular and soft tissue repair patches market is poised for sustained growth.

Select Competitors (Total 42 Featured) -

  • Abbott (St Jude Medical)
  • Admedus
  • Atriummed
  • B.Braun
  • Bard Peripheral Vascular, Inc.
  • Baxter
  • CorMatrix
  • Cryolife, Inc.
  • Edwards Life Sciences Corporation
  • GETINGE Group
  • Glycar SA Pty Ltd.
  • Gunze Limited
  • LabCor
  • LeMaitre Vascular Inc.
  • Maverick Bioscience
  • Medtronic
  • Neovasc
  • Novomedics
  • Perouse Medical
  • Southern Lights Biomaterials
  • TEI Biosciences Inc.
  • Terumo Medical Corporation
  • W.L. Gore & Associates, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Cardiovascular and Soft Tissue Repair Patches - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Biomaterials and Biotechnology Drive Innovations in Cardiovascular and Soft Tissue Repair Patches
    • Increasing Incidences of Cardiovascular Diseases Worldwide Propel the Use of Repair Patches in Surgeries
    • Growth in Minimally Invasive Surgical Techniques Boosts Demand for Cardiovascular Patches
    • Innovations in Drug-Eluting and Bioactive Patches Enhance Healing and Functional Integration
    • Rising Demand for Durable and Biocompatible Soft Tissue Repair Solutions
    • Development of Synthetic and Natural Patches to Meet Diverse Clinical Needs
    • Expansion of Treatment Indications for Repair Patches Beyond Cardiovascular Applications
    • Consumer Awareness and Surgeon Advocacy Play Crucial Roles in the Adoption of New Patch Technologies
    • Technological Enhancements in Imaging and Placement Techniques for Precision in Patch Application
    • Market Trends Toward Customizable and Patient-Specific Repair Patch Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for ePTFE by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Biomaterial & Tissue Engineered Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Biomaterial & Tissue Engineered Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Biomaterial & Tissue Engineered Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Raw Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Raw Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Soft Tissue Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Soft Tissue Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Soft Tissue Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cardiac Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cardiac Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Cardiac Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Vascular Repair & Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Vascular Repair & Reconstruction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Vascular Repair & Reconstruction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Pericardial Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Pericardial Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Pericardial Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Dural Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Dural Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Dural Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Cardiovascular and Soft Tissue Repair Patches Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiovascular and Soft Tissue Repair Patches Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Raw Materials - Percentage Breakdown of Value Sales for ePTFE, Biomaterial & Tissue Engineered Material and Other Raw Materials for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Cardiovascular and Soft Tissue Repair Patches by Application - Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Cardiovascular and Soft Tissue Repair Patches by Application - Percentage Breakdown of Value Sales for Soft Tissue Repair, Cardiac Repair, Vascular Repair & Reconstruction, Pericardial Repair and Dural Repair for the Years 2014, 2024 & 2030

IV. COMPETITION